1-2 of 2
Gerit-Holger Schernthaner, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome+ CML

Emir Hadzijusufovic, DVM, Karin Albrecht-Schgoer, PhD, Kilian Huber, PhD, Florian Grebien, PhD, Gregor Eisenwort, MD PhD, Wilfried Schgoer, MD PhD, Christoph Kaun, Susanne Herndlhofer, Markus Theurl, PhD, Sabine Cerny-Reiterer, DVM, Gregor Hoermann, MD PhD, Wolfgang R Sperr, MD, Uwe Rix, PhD, Irina Sadovnik, MSc, Bernd Jilma, MD, Gerit Holger Schernthaner, MD, Johann Wojta, PhD, Dominik Wolf, MD, Giulio Superti-Furga, PhD, Rudolf Kirchmair, MD, Peter Valent, MD
Journal: Blood
Blood (2014) 124 (21): 1800.
https://doi.org/10.1182/blood.V124.21.1800.1800
Published: 2014
Journal Articles

The Target Receptor Siglec-3 (CD33) Is Expressed on AML Stem Cells in a Majority of All Patients with AML.

Alexander W. Hauswirth, MD, Stefan FLorian, MD, Maria-Theresa Krauth, MD, Gerit-Holger Schernthaner, MD, Edgar Selzer, MD, Volker Wacheck, MD, Dieter Printz, Gerhard Fritsch, MD, Karl Sotlar, MD, Wolfgang R. Sperr, MD, Peter Valent, MD
Journal: Blood
Blood (2005) 106 (11): 4324.
https://doi.org/10.1182/blood.V106.11.4324.4324
Published: 2005